Inquiries · Recommendations

Public Inquiry Recommendations

1,814 tracked recommendations 35 inquiries 928 match current filters Page 7 of 19

Recommendations issued by UK statutory and non-statutory inquiries, with their tracked government response and supporting evidence.

Clear

Browse by inquiry

35 inquiries with tracked recs
Inquiry Recs Accepted
Mid Staffs Inquiry 290 281
Manchester Arena Inquiry 169 169
IICSA 107 96
Muckamore Abbey Inquiry 106
Grenfell Tower Inquiry 104 104
Infected Blood Inquiry 103 102
Hyponatraemia Inquiry 96 96
Fuller Inquiry 92 71
Leveson Inquiry 92 77
Vale of Leven Inquiry 75 75
Baha Mousa Inquiry 73 72
Southport Inquiry 67
RHI Inquiry 45 44
COVID-19 Inquiry 44 24
Morecambe Bay Investigation 44 44
Brook House Inquiry 33 28
Bichard Inquiry 31 31
Angiolini Inquiry 30 29
Post Office Horizon Inquiry 27 25
Jermaine Baker Inquiry 26 22
Edinburgh Tram Inquiry 24 21
Daniel Morgan Panel 23 21
Cranston Inquiry 18
Paterson Inquiry 17 15
HIA Inquiry 12 12
Scottish Hospitals Inquiry 11 11
Anthony Grainger Inquiry 9 9
Al-Sweady Inquiry 9 9
Hillsborough Panel 9 5
Fingerprint Inquiry 9 9
ICL Inquiry 7 6
Litvinenko Inquiry 5 5
Azelle Rodney Inquiry 3 3
Billy Wright Inquiry 3 3
Penrose Inquiry 1 1

Recommendations

928 of 1,814 · page 7 of 19
Code Recommendation Inquiry Response
IBI-A-2e Transparency of Scheme Design
The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the …
Infected Blood Inquiry (2025) Accepted
IBI-A-3a HIV Eligibility Start Date
An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.
Infected Blood Inquiry (2025) Accepted
IBI-A-4c Effective Treatment - Earnings Floor
For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or …
Infected Blood Inquiry (2025) Accepted
IBI-A-4d Deeming of Severity Bands
Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation …
Infected Blood Inquiry (2025) Accepted
IBI-A-4e Evidence of Diagnosis Date
Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate …
Infected Blood Inquiry (2025) Accepted
IBI-A-8b Affected Estates
The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 …
Infected Blood Inquiry (2025) Accepted
IBI-A-9a Bereaved Partner Support Scheme
The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to …
Infected Blood Inquiry (2025) Accepted
IBI-1 Compensation Scheme
My principal recommendation remains that a compensation scheme should be set up now
Infected Blood Inquiry (2024) Accepted
IBI-2a UK and Devolved Memorials
A permanent memorial be established in the UK and consideration be given to memorials in each of Northern Ireland, Wales and Scotland. …
Infected Blood Inquiry (2024) Accepted
IBI-2b Treloar's School Memorial
A memorial be established at public expense, dedicated specifically to the children infected at Treloar’s school. The memorial should be such as …
Infected Blood Inquiry (2024) Accepted
IBI-2c Community Support Events
There should be at least three events, approximately six months apart, drawing together those infected and affected, the nature and timing of …
Infected Blood Inquiry (2024) Accepted
IBI-3a Medical Education - Curriculum
The General Medical Council, and NHS Education for Scotland, Health Education and Improvement Wales, Northern Ireland Medical and Dental Training Agency and …
Infected Blood Inquiry (2024) Accepted
IBI-3b Medical Education - Training Materials
They should look favourably upon putting together a package of training materials, with excerpts from oral and written testimony, to underpin what …
Infected Blood Inquiry (2024) Accepted
IBI-3c Inquiry Website Preservation
The Inquiry website is maintained online
Infected Blood Inquiry (2024) Accepted
IBI-4a(i) Duty of Candour - Northern Ireland
Duty of candour: A statutory duty of candour in healthcare should be introduced in Northern Ireland.
Infected Blood Inquiry (2024) Accepted
IBI-4a(ii) Duty of Candour - Scotland and Wales Review
Duty of candour: The operation of the duties of candour in healthcare in Scotland and in Wales should be reviewed, as it …
Infected Blood Inquiry (2024) Accepted
IBI-4a(iii) Duty of Candour - England Review
Duty of candour: The review of the duty of candour currently under way in England should be completed as soon as practicable.
Infected Blood Inquiry (2024) Accepted
IBI-4c(i) Simplify External Regulation
Regulation: That external regulation of safety in healthcare be simplified. As a first step towards this, there should be a UK wide …
Infected Blood Inquiry (2024) Accepted
IBI-4c(ii) Safety Management Systems Coordination
Regulation: That the national healthcare administrations in England, Northern Ireland, Scotland and Wales explore, and if appropriate, support the development and implementation …
Infected Blood Inquiry (2024) Accepted
IBI-4d Patient Records Audit
Patient Records: Before the end of 2027 there should be a formal audit, publicly reported, of the extent of success of digitisation …
Infected Blood Inquiry (2024) Accepted
IBI-4e Cross-Administration Patient Safety Coordination
Coordination of patient records with devolved governments: Consideration should be given by the national healthcare administrations in England, Scotland, Wales and Northern …
Infected Blood Inquiry (2024) Accepted
IBI-6a(i) Hepatologist Oversight and Fibroscan Access
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have been …
Infected Blood Inquiry (2024) Accepted
IBI-6a(iii) Uncertainty About Fibrosis
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Where there is any …
Infected Blood Inquiry (2024) Accepted
IBI-6a(iv) Fibroscan for Liver Imaging
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Fibroscan technology should be …
Infected Blood Inquiry (2024) Accepted
IBI-6a(vi) Commissioning Hepatology Services
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those bodies responsible for …
Infected Blood Inquiry (2024) Accepted
IBI-7a(ii) Tranexamic Acid - Scotland, Wales and NI
In Scotland, Wales and Northern Ireland offering the use of tranexamic acid should be considered a treatment of preference in respect of …
Infected Blood Inquiry (2024) Accepted
IBI-7a(iii) Transfusion Performance Benchmarking
Consideration be given to standardising and benchmarking transfusion performance between hospitals in order to deliver better patient blood management
Infected Blood Inquiry (2024) Accepted
IBI-7b Transfusion 2024 Review Progress
Review of progress towards the Transfusion 2024 recommendations: Progress in implementation of the Transfusion 2024 recommendations be reviewed, and next steps be …
Infected Blood Inquiry (2024) Accepted
IBI-7f(i) Transfusion Outcome Framework
Establishing the outcome of every transfusion: That a framework be established for recording outcomes for recipients of blood components. That those records …
Infected Blood Inquiry (2024) Accepted
IBI-7f(ii) NHSBT Transfusion Outcome Funding
Establishing the outcome of every transfusion: To the extent that the funding for digital transformation does not already cover the setting up …
Infected Blood Inquiry (2024) Accepted
IBI-8a Pre-1996 Transfusion Testing
When doctors become aware that a patient has had a blood transfusion prior to 1996, that patient should be offered a blood …
Infected Blood Inquiry (2024) Accepted
IBI-8b New Patient Registration Screening
As a matter of routine, new patients registering at a practice should be asked if they have had such a transfusion.
Infected Blood Inquiry (2024) Accepted
IBI-9a Haemophilia Peer Review
That peer review of haemophilia care should continue to occur as presently practised, with any necessary support being provided by NHS Trusts …
Infected Blood Inquiry (2024) Accepted
IBI-9b Trust/Board Action on Peer Reviews
That NHS Trusts and Health Boards should be required to deliberate on peer review findings and give favourable consideration to implementing the …
Infected Blood Inquiry (2024) Accepted
IBI-9c Five-Year Peer Review Cycle
A peer review of each centre should take place not less than once every five years.
Infected Blood Inquiry (2024) Accepted
IBI-9d Haemophilia Centre Resources
The necessary administrative and clinical resources should be provided by hospital trusts and boards, integrated care boards, and service commissioners to facilitate …
Infected Blood Inquiry (2024) Accepted
IBI-9e Recombinant Products Over Plasma-Derived
Recombinant coagulation factor products should be offered in place of plasma-derived ones where clinically appropriate. Service commissioners should ensure that such treatment …
Infected Blood Inquiry (2024) Accepted
IBI-9f National Haemophilia Database Support
That the National Haemophilia Database, run by the UKHCDO, merits the support of additional central funding.
Infected Blood Inquiry (2024) Accepted
IBI-10a(i) Patient Satisfaction in Clinical Audits
A clinical audit should as a matter of routine include measures of patient satisfaction or concern, and these should be reported to …
Infected Blood Inquiry (2024) Accepted
IBI-10a(ii) Charity Funding for Patient Advocacy
That the following charities receive funding specifically for patient advocacy: the UK Haemophilia Society; the Hepatitis C Trust; Haemophilia Scotland; the Scottish …
Infected Blood Inquiry (2024) Accepted
IBI-10a(iii) Additional Charity Support
That favourable consideration be given to other charities and organisations supporting people infected and affected that were granted core participant status (as …
Infected Blood Inquiry (2024) Accepted
IBI-10a(v) Yellow Card System Prominence
Steps be taken to give greater prominence to the online Yellow Card system to those receiving drugs or biological products, or who …
Infected Blood Inquiry (2024) Accepted
IBI-12a Implementation Commitment Within 12 Months
Within the next 12 months, the Government should consider and either commit to implementing the recommendations which I make, or give sufficient …
Infected Blood Inquiry (2024) Accepted
IBI-12b Parliamentary Progress Report
During that period, and before the end of this year – the Government should report back to Parliament as to the progress …
Infected Blood Inquiry (2024) Accepted
IBI-12c No Delay to Second Interim Response
This timetable should not interfere with earlier consideration and response to the Recommendations of the Second Interim Report of the Inquiry.
Infected Blood Inquiry (2024) Accepted
IR1-1 Interim Compensation Payments
An interim payment, of no less than £100,000, should be paid to all those infected and all bereaved partners currently registered with …
Infected Blood Inquiry (2022) Accepted
IR2-1 Scheme Eligibility - Infected and Affected Persons
I recommend that the scheme should offer redress to those infected with HCV and/or HIV, and/or HBV (limited to chronic HBV unless …
Infected Blood Inquiry (2023) Accepted
IR2-2 Eligibility Conditions for Infected Persons
I recommend that the conditions of eligibility for admission of relevant infected persons to the scheme should be that: a) they have …
Infected Blood Inquiry (2023) Accepted
IR2-3 Standard of Proof and Automatic Eligibility
As above, save that (a) the last bullet point should read: "eligibility is accepted if the information available points towards eligibility and …
Infected Blood Inquiry (2023) Accepted
IR2-4 Affected Persons Categories
I recommend that the following relevant affected persons should be admitted to the scheme: a) spouses, civil partners and long term cohabitees …
Infected Blood Inquiry (2023) Accepted
‹ Prev Page 7 of 19 Next ›